Colin Bristow
Stock Analyst at UBS
(0)
# 4625
Out of 5,218 analysts
85
Total ratings
28.57%
Success rate
-16.61%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PTC Therapeutics | Maintains: Strong Buy | 47 71 | 46.45 | 52.85% | 3 | Dec 3, 2024 | |
Gilead Sciences | Maintains: Neutral | 70 96 | 91.85 | 4.52% | 3 | Nov 21, 2024 | |
Vertex Pharmaceutica... | Maintains: Strong Buy | 562 586 | 463.5 | 26.43% | 13 | Nov 5, 2024 | |
Amgen | Maintains: Neutral | 335 326 | 270.45 | 20.54% | 7 | Oct 31, 2024 | |
Merck & Co | Maintains: Buy | 142 136 | 102.09 | 33.22% | 5 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 234 202 | 150.04 | 34.63% | 10 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 4 | 1.45 | 175.86% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 6 | 2.03 | 195.57% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 42 41 | 26.32 | 55.78% | 5 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 1 | 0.41 | 143.9% | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 31 | 25.59 | 21.14% | 7 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1090 1099 | 730.7 | 50.4% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 37 | 6.07 | 509.56% | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 56 54 | 12.02 | 349.25% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 164 167 | 123.57 | 35.15% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 428 420 | 789.07 | -46.77% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 12 2 | 7.58 | -73.61% | 2 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 1.81 | 894.48% | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 154 146 | 173.5 | -15.85% | 2 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 73 75 | 55.73 | 34.58% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 26 | 4.38 | 493.61% | 1 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 6.8 | 32.35% | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 195 | 0.4 | 48650% | 2 | Feb 1, 2021 |